Trial intelligence / Profile preview

Peri-Operative Multimodal Injection in Pediatric CP Hip Surgery

NCT04074265Phase 4Completed

Sponsor
University of California, Los Angeles
Start
Dec 2019
Primary completion
Mar 2023
Modality
Recombinant Proteins and Enzymes, Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of ropivacaine, ketorolac, epinephrine in postoperative pain, sponsored by University of California, Los Angeles. Started Dec 2019; status: completed.

02

Drugs

ropivacaineketorolacepinephrine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04074265.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04074265.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call